<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:chebi fb="0" ids="28783">Zinc protoporphyrin</z:chebi> pretreatment protects against temporary focal ischemic brain injury in rats </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is not known whether the zinc or the <z:chebi fb="0" ids="15430">protoporphyrin</z:chebi> portion of <z:chebi fb="0" ids="28783">zinc protoporphyrin</z:chebi> has effects on focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Hence, <z:hpo ids='HP_0000001'>all</z:hpo> three agents were compared with regard to <z:mpath ids='MPATH_124'>infarct</z:mpath> size and <z:hpo ids='HP_0000969'>edema</z:hpo> in a rat model of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Four groups of adult male Sprague-Dawley rats were subjected to 2 hours of temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 22 hours of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>Each group was pretreated 30 minutes before middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> with 0.9% <z:chebi fb="1" ids="26710">NaCl</z:chebi>, and then three groups were given equimolar doses of <z:chebi fb="0" ids="28783">zinc protoporphyrin</z:chebi>, <z:chebi fb="7" ids="49976">zinc chloride</z:chebi>, or <z:chebi fb="0" ids="15430">protoporphyrin</z:chebi>, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Regional cerebral blood flow in the ischemic cortex was monitored with a laser Doppler flowmeter </plain></SENT>
<SENT sid="6" pm="."><plain>Cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size, brain water content, and ion content were measured 24 hours after the <z:hpo ids='HP_0003674'>onset</z:hpo> of occlusion </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Regional cerebral blood flow during middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was approximately 9.2% to 13% of baseline in <z:hpo ids='HP_0000001'>all</z:hpo> four groups </plain></SENT>
<SENT sid="8" pm="."><plain>Brain water content in the infarcted zone after temporary focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in control, <z:chebi fb="0" ids="28783">zinc protoporphyrin</z:chebi>, <z:chebi fb="7" ids="49976">zinc chloride</z:chebi>, and <z:chebi fb="0" ids="15430">protoporphyrin</z:chebi> groups was 85.7%, 80.6%, 85.6%, and 81.4%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Brain <z:chebi fb="199" ids="26708">sodium</z:chebi> content in the same areas in <z:hpo ids='HP_0000001'>all</z:hpo> four groups paralleled the water content </plain></SENT>
<SENT sid="10" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> size in the controls and groups treated with <z:chebi fb="0" ids="28783">zinc protoporphyrin</z:chebi>, zinc, and <z:chebi fb="0" ids="15430">protoporphyrin</z:chebi> was 25.6%, 7.2%, 7.6%, and 7.2%, respectively </plain></SENT>
<SENT sid="11" pm="."><plain>Compared with the control group, the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in <z:hpo ids='HP_0000001'>all</z:hpo> three treated groups was significantly reduced (P &lt; .05) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: The present results indicate that <z:chebi fb="0" ids="28783">zinc protoporphyrin</z:chebi>, but also zinc and <z:chebi fb="0" ids="15430">protoporphyrin</z:chebi>, contribute to brain-protective effects when administered early in a temporary focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model </plain></SENT>
<SENT sid="13" pm="."><plain><z:chebi fb="7" ids="49976">Zinc chloride</z:chebi> reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size but not <z:hpo ids='HP_0000969'>edema</z:hpo> formation when compared with <z:chebi fb="0" ids="28783">zinc protoporphyrin</z:chebi> and <z:chebi fb="0" ids="15430">protoporphyrin</z:chebi> </plain></SENT>
<SENT sid="14" pm="."><plain><z:chebi fb="2" ids="27365">Zinc ion</z:chebi> in vivo has brain-protective effects, confirming in vitro studies previously reported by some but contrary to reports of others </plain></SENT>
<SENT sid="15" pm="."><plain>Blood versus brain neuropil and cell body concentrations of <z:chebi fb="2" ids="27365">zinc ion</z:chebi> need to be studied in the future to define the precise role of zinc in the complex mechanisms involved in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>